|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Gastroenteric tube feeding: Techniques, problems and solutions显示文摘Gastroenteric tube feeding plays a major role in the management of patients with poor voluntary intake,chronic neurological or mechanical dysphagia or gut dysfunction,and patients who are critically ill.However,despite the benefits and widespread use of enteral tube feeding,some patients experience complications.This review aims to discuss and compare current knowledge regarding the clinical application of enteral tube feeding,together with associated complications and special aspects.We conducted an extensive literature search on PubMed,Embase and Medline using index terms relating to enteral access,enteral feeding/nutrition,tube feeding,percutaneous endoscopic gastrostomy/jejunostomy,endoscopic nasoenteric tube,nasogastric tube,and refeeding syndrome.The literature showed common routes of enteral access to include nasoenteral tube,gastrostomy and jejunostomy,while complications fall into four major categories:mechanical,e.g.,tube blockage or removal;gastrointestinal,e.g.,diarrhea;infectious e.g.,aspiration pneumonia,tube site infection;and metabolic,e.g.,refeeding syndrome,hyperglycemia.Although the type and frequency of complications arising from tube feeding vary considerably according to the chosen access route,gastrointestinal complications are without doubt the most common.Complications associated with enteral tube feeding can be reduced by careful observance of guidelines,including those related to food composition,administration rate,portion size,food temperature and patient supervision. | Irina Blumenstein Yogesh M Shastri Jürgen Stein | 2014 | World Journal of Gastroenterology2014，20，26： | 63 |
| 2 | Chronic intestinal failure and short bowel syndrome in Crohn’s disease显示文摘Chronic intestinal failure(CIF)is a rare but feared complication of Crohn’s disease.Depending on the remaining length of the small intestine,the affected intestinal segment,and the residual bowel function,CIF can result in a wide spectrum of symptoms,from single micronutrient malabsorption to complete intestinal failure.Management of CIF has improved significantly in recent years.Advances in home-based parenteral nutrition,in particular,have translated into increased survival and improved quality of life.Nevertheless,60%of patients are permanently reliant on parenteral nutrition.Encouraging results with new drugs such as teduglutide have added a new dimension to CIF therapy.The outcomes of patients with CIF could be greatly improved by more effective prevention,understanding,and treatment.In complex cases,the care of patients with CIF requires a multidisciplinary approach involving not only physicians but also dietitians and nurses to provide optimal intestinal rehabilitation,nutritional support,and an improved quality of life.Here,we summarize current literature on CIF and short bowel syndrome,encompassing epidemiology,pathophysiology,and advances in surgical and medical management,and elucidate advances in the understanding and therapy of CIF-related complications such as catheter-related bloodstream infections and intestinal failure-associated liver disease. | Aysegül Aksan Karima Farrag Irina Blumenstein Oliver Schröder Axel U Dignass Jürgen Stein | 2021 | World Journal of Gastroenterology2021，27，24： | 4 |
| 3 | Relativistic-intensity near-single-cycle light waveforms at kHz repetition rate显示文摘The development of ultra-intense and ultra-short light sources is currently a subject of intense research driven by the discovery of novel phenomena in the realm of relativistic optics,such as the production of ultrafast energetic particle and radiation beams for applications.It has been a long-standing challenge to unite two hitherto distinct classes of light sources:those achieving relativistic intensity and those with pulse durations approaching a single light cycle.While the former class traditionally involves large-scale amplification chains,the latter class places high demand on the spatiotemporal control of the electromagnetic laser field.Here,we present a light source producing waveformcontrolled 1.5-cycle pulses with a 719 nm central wavelength that can be focused to relativistic intensity at a 1 kHz repetition rate based on nonlinear post-compression in a long hollow-core fiber.The unique capabilities of this source allow us to observe the first experimental indications of light waveform effects in laser wakefield acceleration of relativistic energy electrons. | Marie Ouille Aline Vernier Frederik Bohle Maimouna Bocoum Aurelie Jullien Magali Lozano Jean-Philippe Rousseau Zhao Cheng Dominykas Gustas Andreas Blumenstein Peter Simon Stefan Haessler Jerome Faure Tamas Nagy Rodrigo Lopez-Martens | 2020 | Light(Science & Applications)2020，9，1： | 3 |
| 4 | MAINTENANCE BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR RECURRENT TA, T1 AND CARCINOMA IN SITU TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A RANDOMIZED SOUTHWEST ONCOLOGY GROUP STUDY显示文摘 | DONALD L. LAMM BRENT A. BLUMENSTEIN JOHN D. CRISSMAN JAMES E. MONTIE JAMES E. GOTTESMAN BRUCE A. LOWE MICHAEL F. SAROSDY ROBERT D. BOHL H. BARTON GROSSMAN THOMAS M. BECK JOSEPH T. LEIMERT E. DAVID CRAWFORD | 2000 | The Journal of Urology2000，，4： | 2 |
| 5 | Bilater- al orchiectomy with or without flutamide for metastatic prostate cancer显示文摘 | Eisenberger MA Blumenstein BA Crawford ED | 1998 | N Eng J Med1998，339，： | 1 |
| 6 | Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA,T1and carcinoma in situ transitional cell carcinoma of the bladder:a randomized Southwest Oncology Group Study显示文摘 | LAMM DL BLUMENSTEIN BA CRISSMAN JD | 2000 | J Urol2000，163，4： | 1 |
| 7 | Identification of suppressors of cytokine signaling (SOCS) proteins in human gestational tissues:differential regulation is aasociated with the onset of labor显示文摘 | BLUMENSTEIN M BOWEN-SHAUVER JM KEELAN JA | 2002 | J Clin Endocrinol Metab2002，87，3： | 1 |
| 8 | Maintenance ba- cillus Calmettc-Guerin immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a ran- domized Southwest Oncology Group Study 显示文摘 | Lamm DL Blumenstein BA Crissman JD | 2000 | J Urol2000，163，4： | 1 |
| 9 | Cytokines, prostaglandins and parturition 显示文摘 | Keelan JA Blumenstein M Helliwell R J | 2003 | Placenta2003，24，4： | 1 |
| 10 | Maintenance bacillus Calmette-Guerin immunotherapy for recurrent Ta,TI and carcinoma in situ transitional ceil carcinoma of the bladder:a randomized Southwest Oncology Group Study显示文摘 | Larnm D L Blumenstein B A Crissman J D | 2000 | J Urol2000，163，4： | 1 |
| 11 | O- verall survival analysis of a phase II randomized con- trolled trial of a Poxviral-based PSA-targeted immuno-therapy in metastatic castration-resistant prostate cancer 显示文摘 | Kantoff P W Schuetz T J Blumenstein B A | 2010 | J Clin Oncol2010，28，7： | 1 |
| 12 | Alternative splicing of Rac1 generates Rac1 b,a self-activating GTPase显示文摘 | Fiegen D Haeusler LC Blumenstein L | 2004 | J Biol Chem2004，279，6： | 1 |
| 13 | Hypoxia Inhib- its Activin A Production by Term Villous Trophoblast In Vitro 显示文摘 | Blumenstein M Mitchell MD Groome NP | 2008 | Placenta2008，23，10： | 1 |
| 14 | Overall survival analysis of a phase Ⅱ randomized controlled trial of Poxviral -based PSA -targeted imnmnotherapy in metastatic castration-resistant prostate cancer 显示文摘 | Kantoff PW Schuetz TJ Blumenstein BA | 2010 | J Clin Oncol2010，28，7： | 1 |
| 15 | Early ambulation after acute deep vein thrombosis:Is it safe? 显示文摘 | Blumenstein MS | 2007 | J Pediatr Oncol Nurs2007，24，6： | 1 |
| 16 | Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder : a randomized Southwest Ontology Group Study显示文摘 | LammDL Blumenstein BA Crissman JD | 2000 | J Urol2000，163，4： | 1 |
| 17 | Maintenance bacillus Calmette-Guerin immunotherapy for recurrent Ta , Tl and carcinomain situ transitional cell carcinoma of the bladder: a randomized South-west Oncology Group Study显示文摘 | Lamn DL Blumenstein BA ChrismanJD | 2000 | J Urol2000，163，4： | 1 |
| 18 | Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer显示文摘 | Flanigan RC Salmon SE Blumenstein BA | 2001 | N Engl J Med2001，345，： | 1 |
| 19 | Crystal structure of Rnd3/RhoE:functional implications显示文摘 | Fiegen D Blumenstein L Stege P | 2002 | FEBS Lett2002，525，13： | 1 |
| 20 | Cytokines,prostaglandins and parturition-a review显示文摘 | Keelan JA Blumenstein M Helliwell R J | 2003 | Placenta2003，24，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员